{"id":"placebo-for-testosterone-gel","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebos are inert formulations used as control comparators in clinical trials to distinguish true drug effects from placebo response. In this case, it mimics the appearance and administration route of testosterone gel but contains no testosterone or other active hormone. Any observed effects in placebo recipients are attributable to psychological expectation, natural disease progression, or regression to the mean rather than pharmacological action.","oneSentence":"A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:00.790Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control comparator in testosterone replacement therapy trials"}]},"trialDetails":[{"nctId":"NCT04675788","phase":"PHASE4","title":"Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening","status":"COMPLETED","sponsor":"Indiana University","startDate":"2021-09-02","conditions":"Long QT Syndrome, Abnormalities, Drug-Induced","enrollment":73},{"nctId":"NCT07408440","phase":"NA","title":"Transdermal Testosterone Gel for Female Sexual Interest and Arousal Disorder in Peri- and Post Menopause","status":"NOT_YET_RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2026-04-01","conditions":"Menopause, Sexual Dysfunction, Libido Disorder","enrollment":150},{"nctId":"NCT04807894","phase":"PHASE4","title":"Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo","status":"RECRUITING","sponsor":"Maimonides Medical Center","startDate":"2020-11-01","conditions":"Recurrent Urinary Tract Infection, Vaginal Atrophy, Postmenopausal Disorder","enrollment":100},{"nctId":"NCT02256865","phase":"EARLY_PHASE1","title":"Hormonal Mechanisms of Sleep Restriction","status":"COMPLETED","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2014-10","conditions":"Insulin Resistance","enrollment":40},{"nctId":"NCT06253702","phase":"PHASE4","title":"Brain Blood Flow Responses to Stress: Sex Differences","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2024-07-24","conditions":"Cerebrovascular Disorders","enrollment":22},{"nctId":"NCT04301765","phase":"PHASE2","title":"Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency","status":"RECRUITING","sponsor":"Seattle Institute for Biomedical and Clinical Research","startDate":"2021-01-12","conditions":"Hypogonadism, Male, Cancer, Fatigue","enrollment":230},{"nctId":"NCT02938923","phase":"PHASE3","title":"Starting a Testosterone and Exercise Program After Hip Injury","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2019-03-05","conditions":"Hip Fracture, Frailty, Sarcopenia","enrollment":129},{"nctId":"NCT06794346","phase":"PHASE2","title":"Sexual Effects of Transdermal or Vaginal Testosterone","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Sao Paulo General Hospital","startDate":"2020-10-01","conditions":"Female Sexual Dysfunction, Postmenopausal Symptoms, Testosterone Deficiency","enrollment":132},{"nctId":"NCT02758431","phase":"NA","title":"Cardiovascular Outcomes of Low Testosterone","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2016-07-01","conditions":"Hypogonadism","enrollment":232},{"nctId":"NCT02418572","phase":"PHASE3","title":"Testosterone TRANSdermal Gel for Poor Ovarian Responders Trial","status":"TERMINATED","sponsor":"Fundacion Dexeus","startDate":"2015-04","conditions":"Infertility, Poor Ovarian Response","enrollment":290},{"nctId":"NCT05825092","phase":"PHASE2","title":"Effects of Early Testosterone Gel Administration on Physical Performance in the Critically Ill","status":"RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2023-07-21","conditions":"Critical Illness","enrollment":600},{"nctId":"NCT05484167","phase":"PHASE4","title":"Natesto Testosterone Nasal Gel for Hypogonadal Men","status":"WITHDRAWN","sponsor":"University of Utah","startDate":"2023-01-01","conditions":"Erectile Dysfunction, Sexual Dysfunction","enrollment":""},{"nctId":"NCT00694733","phase":"NA","title":"Regulation of Cortisol Metabolism and Fat Patterning","status":"UNKNOWN","sponsor":"Oregon Health and Science University","startDate":"2005-05","conditions":"Obesity, Menopausal Syndrome","enrollment":140},{"nctId":"NCT02367105","phase":"PHASE3","title":"Lifestyle Intervention and Testosterone Replacement in Obese Seniors","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2015-02-01","conditions":"Obesity and Hypogonadism","enrollment":83},{"nctId":"NCT02349386","phase":"PHASE2","title":"Maintaining Suppression of Testosterone With Transdermal Estradiol Gel","status":"TERMINATED","sponsor":"BHR Pharma, LLC","startDate":"2015-07","conditions":"Cancer of the Prostate","enrollment":34},{"nctId":"NCT00612742","phase":"PHASE3","title":"Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women","status":"COMPLETED","sponsor":"BioSante Pharmaceuticals","startDate":"2008-01","conditions":"Hypoactive Sexual Desire Disorder","enrollment":3656},{"nctId":"NCT01585831","phase":"NA","title":"Study of Psychological and Motor Effects of Testosterone in Adolescents With XXY/Klinefelter Syndrome","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2012-03","conditions":"Klinefelter Syndrome, XXY Syndrome","enrollment":48},{"nctId":"NCT01201863","phase":"PHASE4","title":"Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy","status":"COMPLETED","sponsor":"Craig Hospital","startDate":"2010-09","conditions":"Endocrine Dysfunction, Trauma, Brain Injury","enrollment":46},{"nctId":"NCT04831099","phase":"PHASE3","title":"Testosterone Treatment in a Patient With 17β-hydroxysteroid Dehydrogenase Type 3 Deficiency: an N-of-1 Study","status":"UNKNOWN","sponsor":"Erasmus Medical Center","startDate":"2021-06-01","conditions":"Disorder of Sex Development, 46,XY","enrollment":1},{"nctId":"NCT02419105","phase":"PHASE3","title":"Effects of Transdermal Testosterone and/or Monthly Vitamin D on Fall Risk in Pre--frail Hypogonadal Seniors","status":"TERMINATED","sponsor":"University of Zurich","startDate":"2015-09","conditions":"Hypogonadism, Pre-frail Seniors","enrollment":91},{"nctId":"NCT02147964","phase":"PHASE2","title":"ITT-5 Mechanisms of Spermatogenesis in Man","status":"WITHDRAWN","sponsor":"University of Washington","startDate":"2019-06","conditions":"Gonadotropin Deficiency","enrollment":""},{"nctId":"NCT03000127","phase":"PHASE2","title":"Testosterone for Fatigue in Men With MS","status":"WITHDRAWN","sponsor":"University of California, Los Angeles","startDate":"2018-07-01","conditions":"Multiple Sclerosis","enrollment":""},{"nctId":"NCT02513940","phase":"PHASE4","title":"Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes","status":"COMPLETED","sponsor":"Indiana University","startDate":"2016-05","conditions":"Long QT Syndrome","enrollment":14},{"nctId":"NCT00799617","phase":"PHASE3","title":"The Testosterone Trials in Older Men","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2009-11","conditions":"Andropause","enrollment":790},{"nctId":"NCT01376349","phase":"PHASE3","title":"Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2011-07","conditions":"Breast Cancer, Gynecologic Cancer","enrollment":464},{"nctId":"NCT00104572","phase":"PHASE2","title":"Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.","status":"COMPLETED","sponsor":"National Institute on Aging (NIA)","startDate":"2004-03","conditions":"Hypogonadism, Diabetes, Sarcopenia","enrollment":44},{"nctId":"NCT00190060","phase":"PHASE4","title":"Study of The Effects of Testosterone in Frail Elderly Men","status":"COMPLETED","sponsor":"Manchester University NHS Foundation Trust","startDate":"2004-10","conditions":"Frailty, Sarcopenia","enrollment":262},{"nctId":"NCT02667561","phase":"PHASE1","title":"Pharmacokinetics, Pharmacodinamic and Safety of Testosterone Gel 1%","status":"WITHDRAWN","sponsor":"Biolab Sanus Farmaceutica","startDate":"2017-07","conditions":"Post-menopausal Period","enrollment":""},{"nctId":"NCT01686828","phase":"PHASE1, PHASE2","title":"T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin","status":"COMPLETED","sponsor":"University of Washington","startDate":"2013-06","conditions":"Insulin Resistance, Type 2 Diabetes Mellitus, Obesity","enrollment":53},{"nctId":"NCT00345969","phase":"PHASE3","title":"Exercise and Testosterone Therapy in Elderly Men With Physical Frailty","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2004-11","conditions":"Physical Frailty, Hip Fracture, Elective Hip Replacement","enrollment":25},{"nctId":"NCT01327495","phase":"PHASE2, PHASE3","title":"PROS-2 Dose Response Effects of Exogenous Testosterone on the Prostate","status":"COMPLETED","sponsor":"University of Washington","startDate":"2011-10","conditions":"Healthy","enrollment":62},{"nctId":"NCT03281187","phase":"PHASE3","title":"Efficacy and Safety of Testosterone Nasal Gel for Treating Hypogonadism in Men.","status":"UNKNOWN","sponsor":"FBM Industria Brasileira Ltda","startDate":"2018-07-16","conditions":"Hypogonadism","enrollment":228},{"nctId":"NCT02317640","phase":"PHASE1, PHASE2","title":"TRT in Combination With Electrical Stimulation and Standing: Effect on Muscle and Bone in Spinal Cord Injured Males","status":"UNKNOWN","sponsor":"Kessler Foundation","startDate":"2017-03-15","conditions":"Spinal Cord Injury","enrollment":56},{"nctId":"NCT01377103","phase":"NA","title":"Testosterone Therapy in Heart Failure","status":"WITHDRAWN","sponsor":"Cedars-Sinai Medical Center","startDate":"2011-07","conditions":"Heart Failure, Hypogonadism","enrollment":""},{"nctId":"NCT00287586","phase":"PHASE4","title":"Testosterone Replacement in Older Men and Atherosclerosis Progression","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2004-09","conditions":"Hypogonadism, Atherosclerosis","enrollment":308},{"nctId":"NCT00512707","phase":"PHASE4","title":"Effect of Testosterone in Men With Erectile Dysfunction","status":"COMPLETED","sponsor":"Boston University","startDate":"2006-11","conditions":"Erectile Dysfunction, Testosterone Deficiency, Diabetes","enrollment":140},{"nctId":"NCT00144391","phase":"PHASE4","title":"Testosterone Gel Applied to Women With Pituitary Gland Problems","status":"COMPLETED","sponsor":"Charles Drew University of Medicine and Science","startDate":"2003-07","conditions":"Panhypopituitarism","enrollment":20},{"nctId":"NCT03118479","phase":"PHASE1","title":"Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH)","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2010-05","conditions":"Hypogonadotropic Hypogonadism, Kallmann Syndrome","enrollment":7},{"nctId":"NCT00240981","phase":"PHASE4","title":"TOM: Testosterone in Older Men With Sarcopenia","status":"TERMINATED","sponsor":"Boston Medical Center","startDate":"2005-01","conditions":"Sarcopenia, Hypogonadism, Muscular Diseases","enrollment":209},{"nctId":"NCT02317263","phase":"PHASE2","title":"A Trial to Investigate the Effectiveness of Testosterone Treatment in Men With Multiple Sclerosis","status":"WITHDRAWN","sponsor":"University of California, Los Angeles","startDate":"","conditions":"Multiple Sclerosis","enrollment":""},{"nctId":"NCT00839319","phase":"PHASE1, PHASE2","title":"HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone","status":"COMPLETED","sponsor":"University of Washington","startDate":"2009-03","conditions":"Healthy Males","enrollment":59},{"nctId":"NCT00254553","phase":"PHASE2","title":"A Study to Test a Measure of Symptoms of Older Men With Low Testosterone On and Off Testosterone Replacement Treatment (P05815)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2005-07","conditions":"Hypogonadism","enrollment":150},{"nctId":"NCT00848497","phase":"EARLY_PHASE1","title":"Testosterone for Penile Rehabilitation After Radical Prostatectomy","status":"TERMINATED","sponsor":"Mohit Khera","startDate":"2007-11","conditions":"Hypogonadism, Erectile Dysfunction","enrollment":3},{"nctId":"NCT00433199","phase":"PHASE3","title":"Testosterone Treatment for Hypogonadal Men","status":"COMPLETED","sponsor":"Abbott","startDate":"2007-02","conditions":"Hypogonadism","enrollment":274},{"nctId":"NCT00969163","phase":"PHASE1","title":"A Study to Investigate Biomarkers of Skin Androgenization Following Testosterone Administration (0000-015)(COMPLETED).","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2004-10","conditions":"Skin Androgenization","enrollment":30},{"nctId":"NCT01270841","phase":"PHASE2","title":"Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism","status":"COMPLETED","sponsor":"Repros Therapeutics Inc.","startDate":"2011-01","conditions":"Secondary Hypogonadism","enrollment":83},{"nctId":"NCT00539305","phase":"PHASE3","title":"Hormone and Information Processing Study","status":"COMPLETED","sponsor":"University of Washington","startDate":"2009-07","conditions":"Mild Cognitive Impairment, Alzheimer's Disease","enrollment":22},{"nctId":"NCT00185198","phase":"PHASE3","title":"Efficacy and Safety of Testogel® in Men With Partial Androgen Deficiency of Aging Males (PADAM)","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-09","conditions":"Androgens (Deficiency), Male","enrollment":363},{"nctId":"NCT01215292","phase":"PHASE1, PHASE2","title":"ITT4 Intratesticular Hormonal Milieu in Man (ITT4)","status":"COMPLETED","sponsor":"University of Washington","startDate":"2011-01","conditions":"Healthy Males","enrollment":46},{"nctId":"NCT00490555","phase":"PHASE2, PHASE3","title":"PROS-1-Male Hormonal Contraceptive Regimens on Prostate Tissue","status":"COMPLETED","sponsor":"University of Washington","startDate":"2009-01","conditions":"Healthy","enrollment":32},{"nctId":"NCT01235754","phase":"PHASE3","title":"Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)","status":"COMPLETED","sponsor":"BioSante Pharmaceuticals","startDate":"2010-10","conditions":"Hypoactive Sexual Desire Disorder","enrollment":626},{"nctId":"NCT00613002","phase":"PHASE3","title":"Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women","status":"COMPLETED","sponsor":"BioSante Pharmaceuticals","startDate":"2006-12","conditions":"Hypoactive Sexual Desire Disorder","enrollment":597},{"nctId":"NCT00657501","phase":"PHASE3","title":"Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women","status":"COMPLETED","sponsor":"BioSante Pharmaceuticals","startDate":"2008-03","conditions":"Hypoactive Sexual Desire Disorder","enrollment":575},{"nctId":"NCT00487734","phase":"PHASE4","title":"Effect of Testosterone Replacement on Insulin Resistance","status":"COMPLETED","sponsor":"McGuire Research Institute","startDate":"2007-08","conditions":"Metabolic Syndrome, Hypogonadism","enrollment":19},{"nctId":"NCT00729859","phase":"PHASE2","title":"CEP-1 Hormonal Regulation of Circulating Endothelial Progenitor Cells and HDL-C in Men","status":"COMPLETED","sponsor":"University of Washington","startDate":"2008-12","conditions":"Healthy","enrollment":31},{"nctId":"NCT00490022","phase":"PHASE1, PHASE2","title":"Effect of Dihydrotestosterone (DHT) on Prostate Tissue [Short Title: DHT-3]","status":"COMPLETED","sponsor":"University of Washington","startDate":"2007-06","conditions":"Healthy","enrollment":31},{"nctId":"NCT00304746","phase":"PHASE4","title":"AndroGel in Men With Major Depression and Incomplete Response to Antidepressant Treatment","status":"COMPLETED","sponsor":"Mclean Hospital","startDate":"2006-04","conditions":"Depressive Disorder, Major","enrollment":100},{"nctId":"NCT00161486","phase":"PHASE1","title":"The Effects of Testosterone on Prostate Tissue (ACYP-1)","status":"COMPLETED","sponsor":"University of Washington","startDate":"2004-07","conditions":"Hypogonadism, Contraception","enrollment":13}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":112,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo for testosterone gel","genericName":"Placebo for testosterone gel","companyName":"McGuire Research Institute","companyId":"mcguire-research-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect. Used for Control comparator in testosterone replacement therapy trials.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}